http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2803366-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a0483ae55829e8f49fc5c31b25a5a89
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y401-01002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y208-03016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y102-03004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y401-01008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
filingDate 2005-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2956d35ec3651d888ab27f4fef850dd6
publicationDate 2015-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2803366-A3
titleOfInvention Compositions for treating or preventing oxalate-related disease
abstract The present invention relates to a pharmaceutical composition comprising one or more oxalate-degrading enzymes, wherein the one or more enzymes are entrapped in a three-dimensional mesh structure made from polymers having pore sizes that allow the enzyme substrates to penetrate the mesh structure to reach the enzymes.
priorityDate 2004-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6355242-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0072855-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6200562-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002102238-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004234514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6033888-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6177478-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9852586-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71081

Total number of triples: 36.